Timing of deep brain stimulation in Parkinson disease: A need for reappraisal?

Annals of Neurology

Volumn 73, Issue 5, 2013, Pages 565-575

  Desouza, Ruth Mary ^a   Moro, Elena ^b   Lang, Anthony E ^c   Schapira, Anthony H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

AGGRESSION; ANXIETY DISORDER; APATHY; BRAIN DEPTH STIMULATION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEPRESSION; DYSKINESIA; DYSTONIA; EROSION; FOREIGN BODY; HUMAN; IMPULSE CONTROL DISORDER; MEDICAL DEVICE COMPLICATION; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SAFETY; SPEECH DISORDER; SUICIDE; SURGICAL INFECTION; SYSTEMATIC REVIEW;

DATABASES, FACTUAL; DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 84878322665     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23890     Document Type: Review

References (113)

1. Twelves D, Perkins KS, Counsell C,. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003; 18: 19-31.
2. Wickremaratchi MM, Ben-Shlomo Y, Morris HR,. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol 2009; 16: 450-456.
3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386.
4. Findley LJ,. The economic impact of Parkinson's disease. Parkinsonism Relat Disord 2007; 13 (suppl): S8-S12.
5. Vossius C, Nilsen OB, Larsen JP,. Parkinson's disease and nursing home placement: the economic impact of the need for care. Eur J Neurol 2009; 16: 194-200.
6. Winter Y, Balzer-Geldsetzer M, Spottke A, et al. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur J Neurol 2010; 17: 1156-1163.
7. Weintraub D, Comella CL, Horn S,. Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 2008; 14: S40-S48.
8. Chen JJ,. Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care 2010; 16 (suppl Implications): S87-S93.
9. Chaudhuri KR, Healy DG, Schapira AH,. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
10. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
11. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.
12. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
13. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
14. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (suppl 14): S290-S304.
15. Volkmann J, Allert N, Voges J, et al. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004; 55: 871-875.
16. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000; 57: 461-465.
17. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012; 79: 55-65.
18. Evidente VG, Premkumar AP, Adler CH, et al. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease. Acta Neurol Scand 2011; 124: 211-214.
19. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010; 25: 578-586.
20. Lang AE, Widner H,. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17 (suppl 3): S94-S101.
21. Morgante L, Morgante F, Moro E, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 2007; 13: 528-531.
22. NICE. Deep brain stimulation for Parkinson's disease. Available at: http:/www.nice.org.uk/IPG019.
23. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006; 21 (suppl 14): S171-S196.
24. NICE. Parkinson's disease. Available at: http:/www.nice.org.uk/CG035.
25. Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011; 26 (suppl 3): S2-S41.
26. Koller WC, Tse W,. Unmet medical needs in Parkinson's disease. Neurology 2004; 62: S1-S8.
27. Poewe W,. Treatments for Parkinson disease-past achievements and current clinical needs. Neurology 2009; 72: S65-S73.
28. Hatano T, Kubo SI, Shimo Y, et al. Unmet needs of patients with Parkinson's disease: interview survey of patients and caregivers. J Int Med Res 2009; 37: 717-726.
29. Schapira AH,. Disease modification in Parkinson's disease. Lancet Neurol 2004; 3: 362-368.
30. Moro E, Lang AE,. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. Expert Rev Neurother 2006; 6: 1695-1705.
31. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68: 165.
32. Moro E, Allert N, Eleopra R, et al. A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. J Neurol 2009; 256: 83-88.
33. Wachter T, Minguez-Castellanos A, Valldeoriola F, et al. A tool to improve pre-selection for deep brain stimulation in patients with Parkinson's disease. J Neurol 2011; 258: 641-646.
34. Krack P, Batir A, Van BN, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
35. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010; 133: 2664-2676.
36. Vitek JL, Lyons KE, Bakay R, et al. Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD). Mov Disord 2010; 25: 1530-1537.
37. Wider C, Russmann H, Villemure JG, et al. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol 2006; 63: 951-955.
38. Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord 2011; 26: 2327-2334.
39. Castrioto A, Lozano AM, Poon YY, et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011; 68: 1550-1556.
40. Follett KA, Torres-Russotto D,. Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target? Parkinsonism Relat Disord 2012; 18 (suppl 1): S165-S167.
41. Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry 2008; 79: 694-699.
42. Fimm B, Heber IA, Coenen VA, et al. Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease. Mov Disord 2009; 24: 1613-1620.
43. Halpern CH, Rick JH, Danish SF, et al. Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease. Int J Geriatr Psychiatry 2009; 24: 443-451.
44. Nazzaro JM, Pahwa R, Lyons KE,. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 606-609.
45. Strutt AM, Simpson R, Jankovic J, York MK,. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol 2012; 19: 121-127.
46. Halim A, Baumgartner L, Binder DK,. Effect of deep brain stimulation on autonomic dysfunction in patients with Parkinson's disease. J Clin Neurosci 2011; 18: 804-806.
47. Witjas T, Kaphan E, Regis J, et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007; 22: 1729-1734.
48. St George RJ, Carlson-Kuhta P, Burchiel KJ, et al. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg 2012; 116: 1347-1356.
49. Rothlind JC, Cockshott RW, Starr PA, Marks WJ Jr,. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. J Int Neuropsychol Soc 2007; 13: 68-79.
50. Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 2009; 256: 1321-1329.
51. Chan DT, Zhu XL, Yeung JH, et al. Complications of deep brain stimulation: a collective review. Asian J Surg 2009; 32: 258-263.
52. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720-2728.
53. Kirsch-Darrow L, Zahodne LB, Marsiske M, et al. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 182-188.
54. Porat O, Cohen OS, Schwartz R, Hassin-Baer S,. Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 2009; 21: 398-405.
55. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614.
56. Peron J, Biseul I, Leray E, et al. Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease. Neuropsychology 2010; 24: 1-8.
57. Demetriades P, Rickards H, Cavanna AE,. Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects. Parkinsons Dis 2011; 2011: 658415.
58. Broen M, Duits A, Visser-Vandewalle V, et al. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011; 17: 413-417.
59. Appleby BS, Duggan PS, Regenberg A, Rabins PV,. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 2007; 22: 1722-1728.
60. Heo JH, Lee KM, Paek SH, et al. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J Neurol Sci 2008; 273: 19-24.
61. Alberts JL, Voelcker-Rehage C, Hallahan K, et al. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients. Brain 2008; 131: 3348-3360.
62. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127.
63. Videnovic A, Metman LV,. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008; 23: 343-349.
64. Amara AW, Watts RL, Walker HC,. The effects of deep brain stimulation on sleep in Parkinson's disease. Ther Adv Neurol Disord 2011; 4: 15-24.
65. Shields DC, Lam S, Gorgulho A, et al. Eyelid apraxia associated with subthalamic nucleus deep brain stimulation. Neurology 2006; 66: 1451-1452.
66. Doshi P, Bhargava P,. Hypersexuality following subthalamic nucleus stimulation for Parkinson's disease. Neurol India 2008; 56: 474-476.
67. Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012; 11: 140-149.
68. Derost PP, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007; 68: 1345-1355.
69. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9: 581-591.
70. Dams J, Bornschein B, Reese JP, et al. Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review. Pharmacoeconomics 2011; 29: 1025-1049.
71. McIntosh E,. Perspective on the economic evaluation of deep brain stimulation. Front Integr Neurosci 2011; 5: 19.
72. Valldeoriola F, Morsi O, Tolosa E, et al. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007; 22: 2183-2191.
73. Spottke EA, Volkmann J, Lorenz D, et al. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol 2002; 249: 759-766.
74. Fraix V, Houeto JL, Lagrange C, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. Neurol Neurosurg Psychiatry 2006; 77: 443-449.
75. Kahn E, D'Haese PF, Dawant B, et al. Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry 2012; 83: 164-170.
76. Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007; 68: 267-271.
77. Agid Y, Schupbach M, Gargiulo M, et al. Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so? J Neural Transm Suppl 2006;(70): 409-414.
78. Okun MS, Wu SS, Foote KD, et al. Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease? Neurosurgery 2011; 69: 357-360.
79. Yamada K, Hamasaki T, Kuratsu J,. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease-retrospective evaluation of postoperative independence in pursuing daily activities. Parkinsonism Relat Disord 2009; 15: 746-751.
80. Deuschl G, Schüpbach M, Knudsen K, et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord 2013; 19: 56-61.
81. Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013; 368: 610-622.
82. Espay AJ, Vaughan JE, Marras C, et al. Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: a decision analysis. Mov Disord 2010; 25: 1456-1463.
83. Merola A, Zibetti M, Artusi CA, et al. Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? J Neurol Neurosurg Psychiatry 2012; 83: 251-257.
84. Olanow CW, Kieburtz K, Schapira AH,. Why have we failed to achieve neuroprotection in Parkinson's disease? Ann Neurol 2008; 64 (suppl 2): S101-S110.
85. Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010; 16: 653-661.
86. Schapira AH, Tolosa E,. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 2010; 6: 309-317.
87. Spieles-Engemann AL, Behbehani MM, Collier TJ, et al. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiol Dis 2010; 39: 105-115.
88. Maesawa S, Kaneoke Y, Kajita Y, et al. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 2004; 100: 679-687.
89. Harnack D, Meissner W, Jira JA, et al. Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism. Exp Neurol 2008; 210: 257-260.
90. Carvalho GA, Nikkhah G,. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 2001; 171: 405-417.
91. Zhao XD, Cao YQ, Liu HH, et al. Long term high frequency stimulation of STN increases dopamine in the corpus striatum of hemiparkinsonian rhesus monkey. Brain Res 2009; 1286: 230-238.
92. Wallace BA, Ashkan K, Heise CE, et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007; 130: 2129-2145.
93. Shaw VE, Keay KA, Ashkan K, et al. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus. Parkinsonism Relat Disord 2010; 16: 338-344.
94. Charles PD, Gill CE, Davis TL, et al. Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat Clin Pract Neurol 2008; 4: 424-426.
95. Wichmann T, DeLong MR,. Deep brain stimulation for neurologic and neuropsychiatric disorders. Neuron 2006; 52: 197-204.
96. Wichmann T, Bergman H, DeLong MR,. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 521-530.
97. Lin TP, Carbon M, Tang C, et al. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 2008; 131: 1373-1380.
98. Eckert T, Tang C, Eidelberg D,. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007; 6: 926-932.
99. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006; 129: 2667-2678.
100. Amtage F, Henschel K, Schelter B, et al. High functional connectivity of tremor related subthalamic neurons in Parkinson's disease. Clin Neurophysiol 2009; 120: 1755-1761.
101. Schapira AH, Obeso J,. Timing of treatment initiation in Parkinson's disease: a need for reappraisal? Ann Neurol 2006; 59: 559-562.
102. Warnke PC,. STN stimulation and neuroprotection in Parkinson's disease-when beautiful theories meet ugly facts. J Neurol Neurosurg Psychiatry 2005; 76: 1186-1187.
103. Hilker R, Portman AT, Voges J, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2005; 76: 1217-1221.
104. Nimura T, Yamaguchi K, Ando T, et al. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. J Neurosurg 2005; 103: 968-973.
105. Temperli P, Ghika J, Villemure JG, et al. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003; 60: 78-81.
106. Hariz MI, Johansson F,. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov Disord 2001; 16: 166-168.
107. Fahn S,. How do you treat motor complications in Parkinson's disease: medicine, surgery, or both? Ann Neurol 2008; 64 (suppl 2): S56-S64.
108. Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
109. Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009; 72: 42-49.
110. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
111. Obeso JA, Olanow W,. Deep brain stimulation for Parkinson's disease: thinking about the long-term in the short-term. Mov Disord 2011; 26: 2303-2304.
112. Hamani C, Richter E, Schwalb JM, Lozano AM,. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2005; 56: 1313-1321.
113. Shichi T, Okiyama R, Yokochi F, et al. Unilateral subthalamic stimulation for early-stage Parkinson's disease [in Japanese]. No To Shinkei 2005; 57: 495-498.